Health Services Research - Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the United States
June 1, 2006 -- Effective management of pain often requires the use of opioid analgesics (American Pain Society 1999, 2002; World Health Organization 2000; American...
Business Wire - Altea Therapeutics Commences Phase 1 Clinical Trials of a Novel Fentanyl Citrate Transdermal Patch Designed for the Safe and Rapid Management of Moderate to...
May 25, 2006 -- ATLANTA -- Altea Therapeutics announced today that it has commenced Phase 1 clinical trials in the U.S. for AT3022, the Company's fentanyl citrate...
Skin & Allergy News - With Palladone pulled, FDA eyes other opioids: concern that other extended-relief products may interact fatally with alcohol triggers scrutiny
September 1, 2005 -- Shortly after Purdue Pharma announced in July that it was taking its 24-hour opioid Palladone off the market due to a potentially fatal interaction...
Internal Medicine News - Palladone pulled; FDA examines related opioids
August 15, 2005 -- Shortly after Purdue Pharma announced in July that it was taking its 24-hour opioid Palladone off the market due to a potentially fatal interaction...
M2 Presswire - FDA asks Purdue Pharma to withdraw Palladone for safety reasons.
July 19, 2005 -- M2 PRESSWIRE-19 July 2005-US FDA: FDA asks Purdue Pharma to withdraw Palladone for safety reasons(C)1994-2005 M2 COMMUNICATIONS LTD...
OB/GYN News - Palladone withdrawal prompts added review
August 15, 2005 -- Shortly after Purdue Pharma announced last month that it was taking its 24-hour opioid Palladone off the market due to a potentially fatal...
Skin & Allergy News - Palladone, Abilify
December 1, 2004 -- Palladone (hydromorphone hydrochloride extended release, Purdue Pharma) An extended-release formulation of the opioid agonist for managing...
Internal Medicine News - Palladone, abilify
November 15, 2004 -- Palladone (hydromorphone hydrochloride extended release, Purdue Pharma) An extended-release formulation of the opioid agonist for managing...
